Apollomics (APLM) Liabilities and Shareholders Equity (2022 - 2025)
Apollomics (APLM) posted quarterly Liabilities and Shareholders Equity of $6.7 million for Q4 2025, down 90.59% quarter-over-quarter from $71.4 million in Q2 2023.
Apollomics (APLM) Liabilities and Shareholders Equity (2022 - 2025) Analysis & Trends
Apollomics (APLM) has reported Liabilities and Shareholders Equity for 3 consecutive years, with $6.7 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Liabilities and Shareholders Equity changed N/A year-over-year to $6.7 million; the TTM figure through Dec 2025 stood at $154.6 million (changed N/A YoY), while the FY2025 annual figure was $6.7 million, changed N/A from the prior year.
- Liabilities and Shareholders Equity slipped to $6.7 million in Q4 2025 per APLM's latest filing, from $71.4 million in the prior quarter.
- Across five years, Liabilities and Shareholders Equity topped out at $76.5 million in Q4 2022 and bottomed at $6.7 million in Q4 2025.
- Historically, Liabilities and Shareholders Equity has averaged $51.5 million across 3 years, with a median of $71.4 million in 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 27.42 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 41.73 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 10.03 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 10.96 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 9.18 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 5.56 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 25.60 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 2.10 Bn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 19.82 Bn |
| 10 | Apollomics | 35.18 Mn | 31.90 Mn | - | 6.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 6.71 Mn |
| Jun 30, 2023 | 71.38 Mn |
| Dec 31, 2022 | 76.48 Mn |